Skip to main navigation
Skip to search
Skip to main content
Technical University of Munich Home
Help & FAQ
English
Deutsch
Home
Profiles
Research units
Projects
Research output
Equipment
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Study of 90 hepatitis B surface antigen carriers in Israel
D. Shouval
, R. Tur-Kaspa
, R. Adler
, N. Mani
, S. Penchas
,
M. Roggendorf
, G. Frosner
, M. Eliakim
Institute of Virology
Hadassah Hebrew University Medical Center
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Study of 90 hepatitis B surface antigen carriers in Israel'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hepatitis B Surface Antigen (HBsAg)
100%
Hepatitis B e Antigen (HBeAg)
100%
Israel
100%
Antigen Carrier
100%
Possible Sources
50%
Liver Biopsy
50%
Hepatitis B Virus Infection
50%
Anti-HBc
50%
Chronic Active Hepatitis
50%
Infection Process
50%
Histological Changes
50%
Family Contact
50%
Splenomegaly
50%
Minor Abnormalities
50%
Jews
50%
Jerusalem
50%
Drug Addiction
50%
Dental Treatment
50%
Liver Function Tests
50%
Donor Blood
50%
North African Jews
50%
Anti-HAV
50%
Carrier State
50%
Hepatitis A Antibodies
50%
One Percent
50%
Hepatitis B Core-related Antigen
50%
Medicine and Dentistry
Hepatitis B Antigen
100%
Hepatitis B Core Antibody
100%
Heterozygote
50%
Infection
50%
Hepatitis B
50%
Chronic Active Hepatitis
50%
Hepatitis B(e) Antigen
50%
Hepatitis A Virus
50%
Liver Biopsy
50%
Hepatitis B(e) Antibody
50%
Splenomegaly
50%
Substance Use Disorder
50%
Dental Treatment
50%
Dental Procedure
50%
Liver Function Test
50%
Hepatitis A Antibody
50%
Immunoglobulin M
50%
Immunology and Microbiology
HBsAg
100%
Hepatitis B Core Antibody
100%
Hepatitis B Antigen
100%
Immunoglobulin M
50%
Hepatitis A Antibody
50%
Hepatitis B(e) Antibody
50%
Liver Function
50%
Hepatitis B(e) Antigen
50%
Hepatitis A Virus
50%
Hepatitis B
50%
Heterozygote
50%
Infection
50%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis B Core Antibody
100%
Hepatitis B Antigen
100%
Infection
50%
Hepatitis B
50%
Chronic Active Hepatitis
50%
Hepatitis A Virus
50%
Hepatitis B(e) Antigen
50%
Hepatitis B(e) Antibody
50%
Drug Dependence
50%
Hepatitis A Antibody
50%
Immunoglobulin M
50%
Splenomegaly
50%